Chronic Plaque-type Psoriasis
6 clinical trials · Condition
◉ Watch Chronic Plaque-type Psoriasis
| Record | Firm | Date |
|---|---|---|
| A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis (NCT04207801) | Aurigene Discovery Technologies Limited | 2020-01-21 |
| Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab (NCT03553823) | Novartis Pharmaceuticals | 2019-01-14 |
| Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis (NCT02074982) | Novartis Pharmaceuticals | 2014-02-26 |
| Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis (NCT01828086) | Novartis Pharmaceuticals | 2013-06-01 |
| A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis (NCT01071252) | Novartis Pharmaceuticals | 2010-03-01 |
| AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis (NCT00941031) | Novartis Pharmaceuticals | 2009-07-01 |
Track Chronic Plaque-type Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.